Evidence map›Paper›PMID 25206819›Full record

ReviewNeural regeneration research2014

The Olig family affects central nervous system development and disease.

Botao Tan, Jing Yu, Ying Yin, Gongwei Jia, Wei Jiang, Lehua Yu

Open access · goldAbstract readReview
In one paragraph

Review in Neural regeneration research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Temporal Transcriptional Regulation of Human Neuronal Differentiation via Forward Programming.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Botao TanDepartment of Rehabilitation Medicine, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Jing YuDepartment of Rehabilitation Medicine, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Ying YinDepartment of Rehabilitation Medicine, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Gongwei JiaDepartment of Rehabilitation Medicine, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Wei JiangDepartment of Rehabilitation Medicine, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Lehua YuDepartment of Rehabilitation Medicine, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Dalian Medical University · CNChongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neural cell differentiation and maturation is a critical step during central nervous system development. The oligodendrocyte transcription family (Olig family) is known to be an important factor in regulating neural cell differentiation. Because of this, the Olig family also affects acute and chronic central nervous system diseases, including brain injury, multiple sclerosis, and even gliomas. Improved understanding about the functions of the Olig family in central nervous system development and disease will greatly aid novel breakthroughs in central nervous system diseases. This review investigates the role of the Olig family in central nervous system development and related diseases.

Indexed as

astrocytesbrain injurycentral nervous system diseasedemyelinationdevelopmentdifferentiationnerve regenerationneural regenerationNSFC grantOlig familyoligodendrocytesreviewspinal cord injury

Identifiers

PMID25206819
PMCPMC4146145
OpenAlexW2071004303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.